Menu

• Ask a Health Expert about BACTERIA URINE IDENTIFIED
• Post Your Side Effect related to BACTERIA URINE IDENTIFIED
• BACTERIA URINE IDENTIFIED and FDA Warnings
• BACTERIA URINE IDENTIFIED in Patients Wiki
• Report BACTERIA URINE IDENTIFIED in Drug Side Effect Survey

BACTERIA URINE IDENTIFIED side effect

What is BACTERIA URINE IDENTIFIED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Diphenhydramine Side Effects Report #5688080-7
Physician from UNITED STATES reported DIPHENHYDRAMINE problem on Mar 12, 2008. Female patient, 33 years of age, was diagnosed with suicide attempt and was treated with DIPHENHYDRAMINE. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood creatine increased, electrocardiogram qt prolonged, intentional overdose, protein urine present, rhabdomyolysis, sedation, suicide attempt, . DIPHENHYDRAMINE dosage: 2500 MG, ONCE/SINGLE, ORAL. Patient was hospitalized. Patient recovered.

Valtrex Side Effects Report #5591854-4
VALTREX problem was reported by a Consumer or non-health professional from SWEDEN on Jan 08, 2008. Male patient, 35 years of age, was diagnosed with herpes simplex and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood creatinine increased, c-reactive protein increased, confusional state, cotard's syndrome, delusion, hypertension, oral pain, . VALTREX dosage: 500MG TWICE PER DAY. During the same period patient was treated with ACYCLOVIR, VOLTAREN, LANSOPRAZOLE, TEGRETOL, BACTRIM, PREDNISOLONE, NYSTATIN, NEORAL. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5599218-4
Health Professional from UNITED STATES reported TYSABRI problem on Jan 04, 2008. Female patient, 28 years of age, weighting 125.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood albumin decreased, blood alkaline phosphatase decreased, blood urine present, colitis, culture stool positive, gastroenteritis, haematocrit decreased, haemoglobin decreased, . TYSABRI dosage: 300 MG; QM; IV. During the same period patient was treated with BACLOFEN, AMANTADINE, ORAL CONTRACEPTIVE, WELLBUTRIN, VITAMIN, BOTOX. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5607407-5
TYSABRI problem was reported by a Health Professional from UNITED STATES on Jan 10, 2008. Female patient was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, depression, escherichia infection, hypoaesthesia, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.


Actos Side Effects Report #5526101-2
Consumer or non-health professional from JAPAN reported ACTOS problem on Nov 15, 2007. Male patient, 74 years of age, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, bleeding time prolonged, bundle branch block right, coagulation time prolonged, diarrhoea, gallbladder disorder, gastric cancer, gastric ulcer, gastritis, . ACTOS dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with NATEGLINIDE, AMARYL, KINDEDAK. Patient was hospitalized. Patient died.

Byetta Side Effects Report #5553395-X
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2007. Female patient, 38 years of age, weighting 235.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, fatigue, nausea, vomiting, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, MERIDIA, GLIPIZIDE. Patient recovered.

Prograf Side Effects Report #5478890-3
Physician from UNITED STATES reported PROGRAF problem on Apr 04, 2007. Male patient, 19 years of age, was diagnosed with prophylaxis against transplant rejection, renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, bacterial pyelonephritis, complications of transplanted kidney, escherichia infection, serratia infection, . PROGRAF dosage: unknown. During the same period patient was treated with ZENAPAX, SEPTRA, SINGULAIR, NORVASC, PREVACID, ASPIRIN. Patient was hospitalized. Patient recovered.

Clamoxyl Side Effects Report #5441980-5
CLAMOXYL problem was reported by a Consumer or non-health professional from FRANCE on Aug 31, 2007. Female patient, 73 years of age, was diagnosed with urinary tract infection, depression and was treated with CLAMOXYL. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood creatine abnormal, dehydration, diarrhoea, hypokalaemia, metabolic acidosis, pyrexia, renal failure acute, . CLAMOXYL dosage: unknown. During the same period patient was treated with DUPHALAC, SEROPRAM, FUROSEMIDE, HEMIGOXINE, EDUCTYL, RAMIPRIL, POTASSIUM CHLORIDE, ASPEGIC. Patient was hospitalized. Patient recovered.

Topotecan Side Effects Report #5409691-X
Health Professional from UNITED STATES reported TOPOTECAN problem on Aug 08, 2007. Female patient, weighting 134.1 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, diarrhoea, flank pain, frequent bowel movements, trichosporon infection, . TOPOTECAN dosage: unknown. During the same period patient was treated with LOVENOX, CIPRO, FENTANYL, FLAGYL, NICODERM, PERCOCET, PHENERGAN. Patient was hospitalized. Patient recovered.


Tacrolimus Side Effects Report #5383488-1
TACROLIMUS problem was reported by a Physician from SPAIN on June 22, 2007. Male patient, 51 years of age, weighting 143.3 lb, was diagnosed with renal transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood creatinine increased, disease recurrence, escherichia infection, pyelonephritis, urinary tract infection, . TACROLIMUS dosage: unknown. During the same period patient was treated with EVEROLIMUS. Patient was hospitalized. Patient recovered.

Pioglitazone Side Effects Report #5386071-7
Physician from UNITED STATES reported PIOGLITAZONE problem on June 29, 2007. Female patient, 36 years of age, weighting 260.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with PIOGLITAZONE. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood potassium decreased, dehydration, hyperglycaemia, loss of consciousness, trichomoniasis, . PIOGLITAZONE dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.

Tacrolimus Side Effects Report #5383488-1
TACROLIMUS problem was reported by a Physician from SPAIN on June 22, 2007. Male patient, 51 years of age, weighting 143.3 lb, was diagnosed with renal transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood creatinine increased, disease recurrence, escherichia infection, pyelonephritis, urinary tract infection, . TACROLIMUS dosage: unknown. During the same period patient was treated with EVEROLIMUS. Patient was hospitalized. Patient recovered.

Pioglitazone Side Effects Report #5386071-7
Physician from UNITED STATES reported PIOGLITAZONE problem on June 29, 2007. Female patient, 36 years of age, weighting 260.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with PIOGLITAZONE. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood potassium decreased, dehydration, hyperglycaemia, loss of consciousness, trichomoniasis, . PIOGLITAZONE dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.

Voltaren Side Effects Report #5762329-4
VOLTAREN problem was reported by a Physician from JAPAN on May 30, 2008. Male patient, weighting 119.0 lb, was diagnosed with cystitis, oedema, insomnia, cerebral infarction, diabetes mellitus, neuralgia and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood creatinine increased, blood urea increased, c-reactive protein increased, cystitis, decubitus ulcer, dehydration, glucose urine, haematuria, . VOLTAREN dosage: unknown. During the same period patient was treated with CLARITHROMYCIN, ALDACTONE, LASIX, VITAMIN A, SLOWHEIM, TICLOPIDINE, AMARYL, MOBIC. Patient was hospitalized. Patient recovered.


Humalog Side Effects Report #5736340-3
Consumer or non-health professional from BRAZIL reported HUMALOG problem on May 06, 2008. Female patient, weighting 125.7 lb, was diagnosed with diabetes mellitus and was treated with HUMALOG. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, dizziness, pneumonia, retching, vomiting, . HUMALOG dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.

Escitalopram Side Effects Report #5757407-X
ESCITALOPRAM problem was reported by a Consumer or non-health professional from GERMANY on May 09, 2008. Female patient, 32 years of age, weighting 309.1 lb, was diagnosed with borderline personality disorder, depression and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, erythema, hepatic steatosis, hepatomegaly, joint effusion, joint swelling, oedema peripheral, overdose, pain in extremity, . ESCITALOPRAM dosage: 40 MG QD PO. During the same period patient was treated with TOPAMAX. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5694406-0
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Apr 03, 2008. Female patient, weighting 112.2 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, diarrhoea, escherichia infection, haematocrit decreased, haemoglobin decreased, hot flush, nausea, neutrophil count decreased, vomiting, . CISPLATIN dosage: 44 MG. During the same period patient was treated with ERBITUX. Patient was hospitalized. Patient recovered.

Furosemide Side Effects Report #5710825-8
FUROSEMIDE problem was reported by a Physician from UNITED STATES on Apr 17, 2008. Male patient, 65 years of age, weighting 154.1 lb, was diagnosed with cardiac failure congestive, fluid overload and was treated with FUROSEMIDE. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, cardio-respiratory arrest, crepitations, dyspnoea, heart rate decreased, hyperhidrosis, hypotension, nausea, . FUROSEMIDE dosage: 200 MG FUROSEMIDE IN 200CC NS 4.2 ML/HOUR IV DRIP. During the same period patient was treated with CARVEDILOL, ASPIRIN, AMIODARONE, MEXILETINE HYDROCHLORIDE, SPIRONOLACTONE, ZOCOR, SYNTHROID. Patient died on 04/15/2008.

Kalium Side Effects Report #5713108-5
Physician from SWITZERLAND reported KALIUM problem on Apr 10, 2008. Female patient, 84 years of age, was diagnosed with essential hypertension, dementia, peripheral arterial occlusive disease and was treated with KALIUM. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, brain compression, fall, inappropriate antidiuretic hormone secretion, infection, subdural haematoma, . KALIUM dosage: unknown. During the same period patient was treated with MAGNESIUM, VITAMIN D, SERESTA, OMEZOL, AMLODIPINE, SYMFONA, PLAVIX, COMILORID. Patient was hospitalized and became disabled. Patient recovered.


Voltaren Side Effects Report #5716388-5
VOLTAREN problem was reported by a Physician from JAPAN on Apr 16, 2008. Male patient, 75 years of age, weighting 119.0 lb, was diagnosed with cystitis, insomnia, cerebral infarction, diabetes mellitus, neuralgia and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood creatinine increased, blood urea increased, c-reactive protein increased, cystitis, decubitus ulcer, dehydration, glucose urine, haematuria, . VOLTAREN dosage: unknown. During the same period patient was treated with CLARITHROMYCIN, ALDACTONE, LASIX, VEGETAMIN A, SLOWHEIM, PANALDINE, AMARYL, MOBIC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5375798-9
Physician from UNITED STATES reported GEMZAR problem on June 05, 2007. Female patient, 62 years of age, weighting 175.9 lb, was diagnosed with lung adenocarcinoma stage iv and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood pressure systolic decreased, cardiac failure congestive, chills, full blood count decreased, malignant neoplasm progression, nausea, night sweats, pneumonia, . GEMZAR dosage: unknown. During the same period patient was treated with ALIMTA, CARBOPLATIN, FOLIC ACID, VITAMIN B12, DECADRON, AMBIEN, ATENOLOL, DUONEB. Patient recovered.

Actos Side Effects Report #5318394-1
ACTOS problem was reported by a Consumer or non-health professional from JAPAN on Apr 20, 2007. Male patient, 74 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, bleeding time prolonged, bundle branch block right, coagulation time prolonged, colonic polyp, diarrhoea, gallbladder disorder, gastric cancer stage iii, gastric ulcer, . ACTOS dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with NATEGLINIDE, AMARYL, KINEDAK. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5308530-5
Physician from UNITED STATES reported BEVACIZUMAB problem on Apr 19, 2007. Male patient, weighting 160.8 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood glucose increased, blood potassium decreased, blood urea increased, blood urine present, cerebral arteriosclerosis, platelet count decreased, protein urine present, urinary sediment present, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, LOVASTATIN, ATENOLOL, LISINOPRIL, ASPIRIN, NITROSTAT, LANTUS. Patient was hospitalized. Patient died on 03/09/2007.

Avonex Side Effects Report #5271611-9
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Female patient, 32 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, cholelithiasis, obesity, staphylococcal infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Avastin Side Effects Report #5273251-4
Physician from UNITED STATES reported AVASTIN problem on Mar 08, 2007. Female patient, 77 years of age, weighting 163.1 lb, was diagnosed with bladder cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: bacteria urine identified, blood pressure increased, blood urine present, computerised tomogram abnormal, confusional state, demyelination, encephalopathy, hypertension, protein urine present, . AVASTIN dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Valtrex Side Effects Report #5672947-X
VALTREX problem was reported by a Consumer or non-health professional from SWEDEN on Mar 18, 2008. Male patient, 35 years of age, was diagnosed with herpes simplex and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: anxiety, bacteria urine identified, blood creatinine increased, c-reactive protein increased, confusional state, cotard's syndrome, dehydration, delusion, depression, . VALTREX dosage: 500MG TWICE PER DAY. During the same period patient was treated with ACYCLOVIR, VOLTAREN, LANSOPRAZOLE, TEGRETOL, BACTRIM, PREDNISOLONE, NYSTATIN, NEORAL. Patient was hospitalized. Patient recovered.

Lioresal Side Effects Report #5616244-7
Physician from UNITED STATES reported LIORESAL problem on Jan 25, 2008. Male patient, 65 years of age, was diagnosed with muscle spasticity and was treated with LIORESAL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bacteria urine identified, hypotension, hypoxia, pneumonia, pseudomonas infection, respiratory failure, sepsis, urinary tract infection, . LIORESAL dosage: unknown. During the same period patient was treated with ORAL CIPROFLOXACIN, INTRAVENOUS DIGOXIN AND FLUIDS. Patient was hospitalized. Patient died on 01/11/2008.

Januvia Side Effects Report #5591174-8
JANUVIA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2008. Male patient, 59 years of age, weighting 196.0 lb, was treated with JANUVIA. After drug was administered, patient experienced the following problems/side effects: back pain, bacteria urine identified, balanoposthitis, blood glucose increased, leukocytoclastic vasculitis, penile abscess, penile necrosis, penis disorder, . JANUVIA dosage: 100 MG/DAILY/PO. During the same period patient was treated with LISINOPRIL, PRAVASTATIN, HUMULIN R. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5510571-X
Physician from UNITED STATES reported MYOZYME problem on Oct 23, 2007. Female patient, weighting 29.98 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, bacteria urine identified, blood ph increased, blood pressure diastolic decreased, diarrhoea, enterococcal infection, escherichia infection, heart rate increased, hydronephrosis, . MYOZYME dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, PREVACID, ENALAPRIL MALEATE, DIGOXIN, MIRALAX, LASIX. Patient was hospitalized. Patient recovered.

Cap Side Effects Report #5411992-6
CAP VORINOSTAT UNK problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Male patient, 63 years of age, weighting 257.0 lb, was diagnosed with bladder cancer, metastasis, bladder cancer stage iv and was treated with CAP VORINOSTAT UNK. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bacteria urine identified, blood creatinine increased, escherichia infection, hypocalcaemia, hypotension, metabolic acidosis, neutropenic sepsis, pleural effusion, . CAP VORINOSTAT UNK dosage: 200 MG DAILY PO. During the same period patient was treated with CAP VORINOSTAT UNK, DOCETAXEL, FLOMAX, PRINIVIL, PYRIDOXINE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5397875-9
Physician from UNITED STATES reported REVLIMID problem on July 16, 2007. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arthralgia, bacteria urine identified, oral infection, osteonecrosis, platelet count decreased, pneumonia parainfluenzae viral, productive cough, staphylococcal infection, stress fracture, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ALBUTEROL, BACTRIM, PROTONIX, PREDNISONE, DILAUDID, ADVIL. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5397875-9
REVLIMID problem was reported by a Physician from UNITED STATES on July 16, 2007. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arthralgia, bacteria urine identified, oral infection, osteonecrosis, platelet count decreased, pneumonia parainfluenzae viral, productive cough, staphylococcal infection, stress fracture, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ALBUTEROL, BACTRIM, PROTONIX, PREDNISONE, DILAUDID, ADVIL. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5756016-6
Physician from JAPAN reported GLEEVEC problem on May 22, 2008. Female patient, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia, asthma and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: asthma, bacteria urine identified, c-reactive protein increased, interstitial lung disease, leukocytosis, pyrexia, wheezing, . GLEEVEC dosage: 400 MG. During the same period patient was treated with HOKUNALIN, PREDONINE, FLUTIDE, GASTER D, PROTECADIN. Patient was hospitalized. Patient recovered.

Naglazyme Side Effects Report #5729880-4
NAGLAZYME problem was reported by a Physician from UNITED STATES on Apr 17, 2008. Male patient, 15 years of age, weighting 48.50 lb, was diagnosed with mucopolysaccharidosis vi and was treated with NAGLAZYME. After drug was administered, patient experienced the following problems/side effects: anaemia, bacteria urine identified, blood potassium decreased, calculus ureteric, catheter site erythema, constipation, ear infection, hydronephrosis, infusion site reaction, . NAGLAZYME dosage: 1 MG/KG; QW; IV. During the same period patient was treated with DIAMOX, ZANTAC, LORATADINE, MONTELUKAST, FLUVOXAMINE MALEATE, CEFAZOLIN, MIRALAX, MOTRIN. Patient was hospitalized. Patient recovered.

Escitalopram Side Effects Report #5755556-3
Health Professional from DENMARK reported ESCITALOPRAM problem on May 09, 2008. Female patient, 32 years of age, weighting 309.1 lb, was diagnosed with borderline personality disorder, depression and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, bacteria urine identified, erythema, hepatic steatosis, hepatomegaly, oedema peripheral, overdose, pancreas lipomatosis, platelet count decreased, . ESCITALOPRAM dosage: 40 MG OD PO. During the same period patient was treated with TOPAMAX. Patient was hospitalized. Patient recovered.

Diphenydramine Side Effects Report #5703000-4
DIPHENYDRAMINE problem was reported by a Physician from UNITED STATES on Mar 25, 2008. Female patient, 33 years of age, was diagnosed with suicide attempt and was treated with DIPHENYDRAMINE. After drug was administered, patient experienced the following problems/side effects: aldolase increased, bacteria urine identified, electrocardiogram qt prolonged, haemoglobin urine present, intentional overdose, lethargy, nitrite urine present, ph urine increased, protein urine present, . DIPHENYDRAMINE dosage: 2500 MG, ONCE/SINGLE, ORAL. Patient was hospitalized. Patient recovered.

Dacogen Side Effects Report #5320112-8
Health Professional from UNITED STATES reported DACOGEN problem on Apr 19, 2007. Male patient, 76 years of age, weighting 220.0 lb, was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: anorexia, bacteria urine identified, blood pressure increased, culture throat positive, dialysis, headache, interstitial lung disease, photophobia, prostatitis, . DACOGEN dosage: 40 MG ; QD; IV. During the same period patient was treated with KYTRIL, ZOLOFT, FLOMAX, PROTONIX. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5328224-X
NATALIZUMAB problem was reported by a Physician from UNITED STATES on May 01, 2007. Female patient, 34 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: addison's disease, bacteria urine identified, coma, condition aggravated, confusional state, delusion, depressed mood, encephalopathy, enterococcal infection, . NATALIZUMAB dosage: 300 MG QW IV. During the same period patient was treated with BACLOFEN, DETROL. Patient was hospitalized. Patient recovered.

Betaseron Side Effects Report #5273028-X
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Mar 07, 2007. Female patient, 39 years of age, weighting 115.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: arthritis enteropathic, bacteria urine identified, vasculitis, . BETASERON dosage: unknown. During the same period patient was treated with BACLOFEN, NEURONTIN, PROZAC, VALIUM, ADDERALL, MIRALAX, ASACOL, ATROVENT. Patient recovered.

Fluorouracil Side Effects Report #5648543-7
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2008. Female patient, weighting 111.8 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anorexia, bacteria urine identified, fatigue, white blood cells urine positive, . FLUOROURACIL dosage: 11175 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient recovered.

Bevacizumab Side Effects Report #5287051-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 19, 2007. Male patient, 68 years of age, weighting 160.7 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, asthenia, bacteria urine identified, blood glucose increased, cerebrovascular disorder, confusional state, depressed level of consciousness, drooling, leukoencephalopathy, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, LOVASTATIN, ATENOLOL, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient died on 03/09/2007.